机构

• 合肥物质科学研究院 [7]
• 数学与系统科学研究院 [1]
• 上海药物研究所 [1]
• 昆明植物研究所 [1]
• 过程工程研究所 [1]
• 近代物理研究所 [1]
• 更多

采集方式

• OAI收割 [12]

内容类型

• 期刊论文 [12]

发表日期

• 2023 [1]
• 2022 [4]
• 2021 [5]
• 2019 [2]

学科主题

筛选

浏览/检索结果: 共12条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Small-Molecule Drugs in Immunotherapy 期刊论文  OAI收割 MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 卷号: 23, 期号: 13, 页码: 1341-1359 作者:  Hao,Xuanrun;  Chen,Zhongliang;  Li,Haining;  Wei,Minqin;  Zuo,Zhili   |  收藏  |  浏览/下载：166/0  |  提交时间：2024/07/25 Cancer immunotherapy  inhibitors  Pd-1/Pd-L1 inhibitor  IDO inhibitor  STING agonists  ROR gamma t agonists  TGF  beta inhibitors  INDOLEAMINE 2,3-DIOXYGENASE  SIGNALING INHIBITOR  DENDRITIC CELLS  GROWTH  TUMOR  PATHWAY  PEMBROLIZUMAB  RECEPTORS  DISCOVERY  VADIMEZAN   Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Wu, Y. -L.;  Zhou, Q.;  Chen, M.;  Pan, Y.;  Jian, O.   |  收藏  |  浏览/下载：49/0  |  提交时间：2022/12/23 CCRT  sCRT  PD-L1 inhibitor   The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文  OAI收割 CANCERS, 2022, 卷号: 14 作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui   |  收藏  |  浏览/下载：38/0  |  提交时间：2022/12/22 liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell   Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Lin, Yuxin;  Zhu, Wei;  Wu, Bingchen;  Lan, Huiyin   |  收藏  |  浏览/下载：62/0  |  提交时间：2022/05/16 Sarcoid-like reaction  immune checkpoint inhibitor  Toripalimab  PD-1  case report   High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文  OAI收割 BMC CANCER, 2022, 卷号: 22 作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao   |  收藏  |  浏览/下载：67/0  |  提交时间：2022/02/14 Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment   The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文  OAI收割 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing   |  收藏  |  浏览/下载：76/0  |  提交时间：2022/01/10 Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event   Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文  OAI收割 CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936 作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan   |  收藏  |  浏览/下载：59/0  |  提交时间：2021/08/17 Cancer immunotherapy  siRNA delivery  Acid-activatible micelleplex  CDK4  6 inhibitor  PD-L1 knockdown   Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy 期刊论文  OAI收割 NEOPLASIA, 2021, 卷号: 23, 期号: 3, 页码: 281-293 作者:  Wang, Fengling;  Ye, Wenling;  Wang, Shuang;  He, Yongxing;  Zhong, Haiyang   |  收藏  |  浏览/下载：47/0  |  提交时间：2021/12/10 PD-1  PD-L1  Inhibitor  APBC  Cancer immunotherapy   Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文  OAI收割 TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14 作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/01/25 Nasopharyngeal carcinoma  Metastasis  Chemotherapy  Recurrence  Anti-PD1 checkpoint inhibitor   Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report 期刊论文  OAI收割 JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2021, 卷号: 14 作者:  Huang, Jiahuan;  Lei, Lei;  Chen, Bo;  Pan, Guoqiang;  Wang, Xiaojiao   |  收藏  |  浏览/下载：37/0  |  提交时间：2021/04/26 chemotherapy  combination therapy  palatine tonsil cancer  PD-1 inhibitor  sarcomatoid carcinoma